Difference between revisions of "Team:TCU Taiwan/Practices"
Phoebe chen (Talk | contribs) |
Phoebe chen (Talk | contribs) |
||
(One intermediate revision by the same user not shown) | |||
Line 218: | Line 218: | ||
</div> | </div> | ||
</div> | </div> | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
<div id="st1" class="st"> | <div id="st1" class="st"> | ||
Line 256: | Line 224: | ||
<table width="100%" align="center"> | <table width="100%" align="center"> | ||
<tr> | <tr> | ||
− | <td align="center"><span style="font-family:Arial Black;color:#000080;font-size:38px;"><font-weight: 700;>National Taiwan Ocean University </br>Meeting with Dr. | + | <td align="center"><span style="font-family:Arial Black;color:#000080;font-size:38px;"><font-weight: 700;>National Taiwan Ocean University </br>Meeting with Dr. Chang-Jer Wu</font></span></td> |
</tr> <tr></br> | </tr> <tr></br> | ||
<td align="left"><span style="font-family:Arial Black;color:#36648B"><font size="5"><font-weight: 800;></br>May 7th,2015</font></span></td> | <td align="left"><span style="font-family:Arial Black;color:#36648B"><font size="5"><font-weight: 800;></br>May 7th,2015</font></span></td> | ||
Line 265: | Line 233: | ||
<td width="5%"></td> | <td width="5%"></td> | ||
<td width="90%"> | <td width="90%"> | ||
− | <span style="font-family:Calibri;text-align:justify;"><font size="5">It’s with great pleasure to invite Dr. | + | <span style="font-family:Calibri;text-align:justify;"><font size="5">It’s with great pleasure to invite Dr. Chang-Jer Wu to share with us his experience. Dr. Chang-Jer Wu has published research on the function of Epinecidin-1 in wounded mice in 2013 (research title: <I>Use of the antimicrobial peptide Epinecidin-1 to protect against MRSA infection in mice with skin injuries</I>). Building on this research, during our preparation, we decided to bring Epinecidin-1 into the wound dressing design. Dr. Chang-Jer Wu’s extensive research experience has made a significant impact on our experimental design and we are grateful and appreciative for his research to translate into constant progress with our project.</font> |
</td> | </td> | ||
<td width="5%"></td> </tr> | <td width="5%"></td> </tr> |
Latest revision as of 13:56, 29 October 2015
Our team upholds the spirit of the iGEM competition of involving a genetically engineered machine. With this platform, we have the possibility to change the world become a better place. Through Moreover we meet with teachers and other iGEM teams to exchange our ideas and experiences. |
Through our page on Facebook, we share our daily lives and encourage people to develop their interest in biological and genetically engineered machine. |
It’s with great pleasure to invite Dr. Chang-Jer Wu to share with us his experience. Dr. Chang-Jer Wu has published research on the function of Epinecidin-1 in wounded mice in 2013 (research title: Use of the antimicrobial peptide Epinecidin-1 to protect against MRSA infection in mice with skin injuries). Building on this research, during our preparation, we decided to bring Epinecidin-1 into the wound dressing design. Dr. Chang-Jer Wu’s extensive research experience has made a significant impact on our experimental design and we are grateful and appreciative for his research to translate into constant progress with our project. |
Dr. Shih Ting Hong, specialist in DA AI Technology has shared his professional insight into the market value and product application. He has also provided invaluable advice towards product packaging designs. Dr. Hong’s experience and advice have provided us focus and allowed us to develop more specific guidelines for our project. |
We appreciate the opportunity to discuss our project with Dr. Hua from Chang Gung University and Chang Gung University iGEM team. |
During a visit to Dr. Wang from Hualien Tzu Chi Hospital Department of Plastic Surgery, he provided valuable clinical experience and recommendations to help us compare our project with some current dressings on the market. |